Provided by Tiger Trade Technology Pte. Ltd.

Monopar Therapeutics

113.30
+1.371.22%
Volume:56.46K
Turnover:6.38M
Market Cap:757.14M
PE:-51.96
High:115.87
Open:110.21
Low:110.21
Close:111.93
52wk High:124.82
52wk Low:32.77
Shares:6.68M
Float Shares:4.48M
Volume Ratio:0.54
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1804
EPS(LYR):-1.8509
ROE:-19.50%
ROA:-14.64%
PB:5.79
PE(LYR):-61.22

Loading ...

Monopar Therapeutics Director Raymond Anderson Sells USD 349,125 of Common Shares

Reuters
·
Aug 28

Monopar Names Jeffrey D. Kent Executive Vice President, Head of Medical Affairs

Reuters
·
Aug 19

Monopar Appoints Jeffrey D. Kent, M.d., as Executive Vice President, Head of Medical Affairs; Announces Two Alxn1840 Presentations at Aasld – the Liver Meeting® 2026

THOMSON REUTERS
·
Aug 19

Morgan Stanley Keeps Their Buy Rating on Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Aug 17

Monopar Therapeutics Shares Drop After Downgrade From Cantor Fitzgerald

MT Newswires Live
·
Aug 14

Monopar Therapeutics is Maintained at Overweight by Barclays

Dow Jones
·
Aug 13

Cantor Fitzgerald Downgrades Monopar Therapeutics to Neutral From Overweight, Adjusts PT to $119 From $109

MT Newswires Live
·
Aug 13

Barclays Reaffirms Their Buy Rating on Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Aug 13

Monopar Therapeutics Inc. : Leerink Partners Raises Target Price to $145 from $115

THOMSON REUTERS
·
Aug 13

Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), AbSci (ABSI)

TIPRANKS
·
Aug 13

Monopar Therapeutics Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Monopar Therapeutics' Q2 Net Loss Widens

MT Newswires Live
·
Aug 12

Monopar Therapeutics Q2 EPS $(0.62) Misses $(0.56) Estimate

Benzinga Earnings
·
Aug 12

Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
Aug 12

Monopar Therapeutics Inc. Expected to Post a Loss of 62 Cents a Share - Earnings Preview

Reuters
·
Aug 08

BTIG’s Mukherjee Initiates Buy on Monopar Therapeutics, Citing Emerging Head & Neck Cancer Data and Favorable Risk‑Reward Setup

TIPRANKS
·
Jul 24

U.S. Research Roundup-alphabet, IBM, Tesla

Reuters
·
Jul 23

Monopar Therapeutics is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 23

Monopar Therapeutics Inc. : H.c. Wainwright Raises Target Price to $125 from $105

THOMSON REUTERS
·
Jul 22

Monopar Starts Rolling FDA NDA Submission for Alxn1840 in Wilson Disease

Reuters
·
Jul 22